- Home
- OVBC vs BCAB Comparison
OVBC vs BCAB Comparison
Compare OVBC & BCAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OVBC
- BCAB
- Stock Information
- Founded
- OVBC 1872
- BCAB 2007
- Country
- OVBC United States
- BCAB United States
- Employees
- OVBC N/A
- BCAB N/A
- Industry
- OVBC Major Banks
- BCAB Medicinal Chemicals and Botanical Products
- Sector
- OVBC Finance
- BCAB Health Care
- Exchange
- OVBC Nasdaq
- BCAB Nasdaq
- Market Cap
- OVBC 114.0M
- BCAB 91.4M
- IPO Year
- OVBC N/A
- BCAB 2020
- Fundamental
- Price
- OVBC $23.93
- BCAB $1.85
- Analyst Decision
- OVBC
- BCAB Strong Buy
- Analyst Count
- OVBC 0
- BCAB 2
- Target Price
- OVBC N/A
- BCAB $6.00
- AVG Volume (30 Days)
- OVBC 3.0K
- BCAB 1.9M
- Earning Date
- OVBC 10-24-2024
- BCAB 11-05-2024
- Dividend Yield
- OVBC 3.68%
- BCAB N/A
- EPS Growth
- OVBC N/A
- BCAB N/A
- EPS
- OVBC 2.36
- BCAB N/A
- Revenue
- OVBC $55,881,000.00
- BCAB N/A
- Revenue This Year
- OVBC N/A
- BCAB N/A
- Revenue Next Year
- OVBC N/A
- BCAB N/A
- P/E Ratio
- OVBC $9.89
- BCAB N/A
- Revenue Growth
- OVBC N/A
- BCAB N/A
- 52 Week Low
- OVBC $19.35
- BCAB $1.14
- 52 Week High
- OVBC $25.50
- BCAB $4.02
- Technical
- Relative Strength Index (RSI)
- OVBC 51.74
- BCAB 47.87
- Support Level
- OVBC $22.98
- BCAB $1.86
- Resistance Level
- OVBC $23.80
- BCAB $2.40
- Average True Range (ATR)
- OVBC 0.56
- BCAB 0.25
- MACD
- OVBC -0.05
- BCAB -0.01
- Stochastic Oscillator
- OVBC 71.49
- BCAB 30.38
About OVBC Ohio Valley Banc Corp.
Ohio Valley Banc Corporation is a financial holding company. The bank is a full-service financial institution offering a blend of commercial and consumer banking services within Southeastern Ohio as well as western West Virginia. The banking services offered by the bank include the acceptance of deposits in checking, savings, time and money market accounts; the making and servicing of personal, commercial, and student loans; and the making of construction and real estate loans. It also offers individual retirement accounts, safe deposit boxes, wire transfers and other standard banking products and services. The bank segmented its operating activities into two reportable segments, Banking and Consumer Finance. The majority of its total revenue is derived from the Banking segment.
About BCAB BioAtla Inc.
BioAtla Inc is a clinical-stage biopharmaceutical company. The company is engaged in the development of a novel class of specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its pipeline products comprise mecbotamab vedotin (BA3011), ozuriftamab vedotin (BA3021), and evalstotug (BA3071), and its Phase 1 clinical trial of BA3182 (CAB-EpCAM x CAB-CD3) and Bispecific antibody programs.